MOONLAKE IMMUNOTHERAPEUTICS
MLTX·61559X104·US·Common Stock·Healthcare - Biotechnology-Activist
CLASS A ORD
MLTX (MOONLAKE IMMUNOTHERAPEUTICS) is held by 81 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($64.3M), D. E. Shaw & Co., Inc. ($44.6M), Point72 Asset Management, L.P. ($25.5M). Net institutional sentiment: Mixed.
81
Holders
(4 Elite)
$436.6M
Total Value
57% (82)
Consensus
47 buying - 35 selling
13F: Insider & Congress:
Who's Trading
InsiderSJSantos da Silva JorgeSell $1.4MJul 10, 2026
InsiderSJSantos da Silva JorgeSell $679KJul 9, 2026
ActivistBVBIOTECHNOLOGY VALUE FUND L P10.2%Jun 29, 2026
ActivistCACormorant Asset Management, LP6.3%May 15, 2026
InsiderBMBodenstedt MatthiasSell $273KMay 11, 2026
InsiderBMBodenstedt MatthiasSell $47KApr 14, 2026
InsiderSJSantos da Silva JorgeSell $946KApr 13, 2026
InsiderSJSantos da Silva JorgeSell $1.8MApr 10, 2026
InsiderBMBodenstedt MatthiasSell $38KApr 10, 2026
InsiderBMBodenstedt MatthiasSell $1.6MApr 9, 2026
Showing 1-20 of 89
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer